We have incorporated these guidelines into our policy for the evaluation of the asymptomatic (≥35-week) infant at risk for EOS (see Fig. 23B.1). g. Treatment of infants with invasive GBS disease. When GBS is identified as the sole causative organism in EOS, empiric antibiotic treatment ...